Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
Cardiac Magnetic Resonance for Tissue Characterization-Based Risk Stratification of Cardiopulmonary Symptoms, Effort Tolerance, and Prognosis Among COVID-19 Survivors
Weill Medical College of Cornell University
510 participants
Jul 1, 2021
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to test if visualizing the heart with cardiac MRI/echo will be important in the understanding cardiac function and prediction of cardiopulmonary symptoms, physical effort tolerance, and outcomes in COVID-19 survivors. If successful, the research will allow us to identify the causes of lasting cardiopulmonary symptoms and begin developing cardiac and lung directed therapies accordingly.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients participate in an NIH funded cardiac MRI to assess their symptoms.
Patients participate in an NIH funded cardiac echocardiogram to assess their symptoms.
Patients participate in a 6-minute walk test to assess their symptoms.
Patients answer a survey-based questionnaire to assess their symptoms.
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05164744